COMPANY · NIPC 503604704

GILEAD SCIENCES, LDA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €1,317,133,868.03 across 5,388 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameGILEAD SCIENCES, LDA
NIPC503604704
Registered officePRC DUQUE SALDANHA, N.º1, 8A E 8B, 1050-094 LISBOA
SourceTED (Jornal Oficial da UE), aviso 658564-2024
Record date29 October 2024

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €15,524,521.6220122013: €19,334,818.842014: €50,863,009.2420142015: €158,185,075.332016: €99,234,142.5320162017: €131,223,825.242018: €31,946,368.9220182019: €58,101,774.292020: €65,654,169.7820202021: €53,251,553.842022: €82,159,155.3520222023: €113,661,492.972024: €140,541,932.4420242025: €144,566,141.372026: €152,885,886.272026€158,185,075.33
Contracted value by year
YearContractsContract value
201259€15,524,521.62
2013106€19,334,818.84
2014148€50,863,009.24
2015938€158,185,075.33
2016532€99,234,142.53
2017434€131,223,825.24
2018311€31,946,368.92
2019332€58,101,774.29
2020307€65,654,169.78
2021303€53,251,553.84
2022352€82,159,155.35
2023434€113,661,492.97
2024440€140,541,932.44
2025381€144,566,141.37
2026311€152,885,886.27
Contracted value by place of performance
NameContractsContract value
Lisboa960€480,715,770.52
Faro275€122,007,536.03
Coimbra653€120,978,018.76
Porto333€99,632,252.76
Vila Nova de Gaia634€52,920,379.14
Barreiro240€49,107,455.22
Amadora77€47,329,715.22
Setúbal235€41,659,965.30
Almada189€32,827,601.83
Funchal211€31,373,462.55
Largest contracts
SubjectYearContract value
Aquisição de Sofosbuvir e Ledipasvir+sofosbuvir apenas representados pela empresa Gilead Sciences, Lda.2017€21,121,187.71
Fornecimento de doses de tratamento de Veklury | Remdesivir2020€19,458,000
Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/304 - Medicamentos do grupo 4: sangue; 2023/305 - Medicamentos do aparelho cardiovascular; 2023/481 - Medicamentos diversos; 2023/491 - Medicamentos do foro oncológic2025€14,581,366.19
Medicamentos anti-infecciosos e antiretrovirais - c/ base no CPA 2013/402015€12,763,207.62
aquisição de Medicamentos Antirretrovirais P259-AC-2017-152017€12,259,098.78

Who they competed with

In 4,917 contracts with a list of competitors, the company took part and was awarded 1,315 (27%).

Companies with the most procedures in common
CompanyProcedures in common
generis154
mylan lda142
teva pharma128
farmoz112
Abbvie. Lda.97
accord healthcare unipessoal, lda87
lABORATÓRIOS PFIZER, LDA85
fresenius kabi84
Merck, Sharph & Dohme, Lda.83
Hikma, Lda.82
Sandoz, Lda.82
janssen Cilag65
roche farmaceutica64
Glaxosmithkline63
viiv62
LOGIFARMA - LOGISTICA FARMACÊUTICA S.A.57
astellas49
Medinfar42
Novartis Farma-Produtos Farmacêuticos, S.A40
Laboratórios Normon, S.A.38
overpharma38
Labesfal, S.A.36
Zentiva, Lda.31
Bristol-Myers Squibb, S.A.29
bayer portugal lda28
tecnimede26
unilfarma25
Baxter Médico Farmacêutica, Lda.24
Lilly Portugal - Produtos Farmacêuticos, Lda.23
B.Braun Medical, Unipessoal Lda.23

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents35 companies and 60 links. The list below gives the same content as text.bayer portugal… (NIPC 500043256)bayer portugal…Bristol-Myers … (NIPC 500048193)Bristol-Myers …Novartis Farma… (NIPC 500063524)Novartis Farma…Glaxosmithkline (NIPC 500139962)GlaxosmithklinelABORATÓRIOS P… (NIPC 500162166)lABORATÓRIOS P…Lilly Portugal… (NIPC 500165602)Lilly Portugal…janssen Cilag (NIPC 500189412)janssen CilagMerck, Sharph … (NIPC 500191360)Merck, Sharph …roche farmaceu… (NIPC 500233810)roche farmaceu…unilfarma (NIPC 500293023)unilfarmaGILEAD SCIENCES, LDA (NIPC 503604704)GILEAD SCIENCES, LDA+24 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.